Crescent biopharma to present at the td cowen 45th annual health care conference

Company to highlight lead program cr-001, a tetravalent vegf1 x pd-1 bispecific antibody in development for treating solid tumors company to highlight lead program cr-001, a tetravalent vegf1 x pd-1 bispecific antibody in development for treating solid tumors
COWN Ratings Summary
COWN Quant Ranking